tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Legend Biotech sees cash runway beyond 2026
PremiumThe FlyLegend Biotech sees cash runway beyond 2026
7d ago
Legend Biotech selloff brings favorable risk/reward, says Deutsche Bank
Premium
The Fly
Legend Biotech selloff brings favorable risk/reward, says Deutsche Bank
8d ago
LEGN Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
LEGN Upcoming Earnings Report: What to Expect?
9d ago
Legend Biotech price target lowered to $80 from $90 at Barclays
PremiumThe FlyLegend Biotech price target lowered to $80 from $90 at Barclays
1M ago
Legend Biotech Reshapes Board, Appoints GenScript Chairman Robin Meng as Director
Premium
Company Announcements
Legend Biotech Reshapes Board, Appoints GenScript Chairman Robin Meng as Director
2M ago
Legend Biotech: Undervalued CARVYKTI Leader Offering a Compelling Buy Opportunity Despite Transient Setback
Premium
Ratings
Legend Biotech: Undervalued CARVYKTI Leader Offering a Compelling Buy Opportunity Despite Transient Setback
2M ago
Legend Biotech Announces Preliminary Q4 2025 CARVYKTI Sales of Approximately $555 Million
PremiumCompany AnnouncementsLegend Biotech Announces Preliminary Q4 2025 CARVYKTI Sales of Approximately $555 Million
2M ago
FDA draft guidance favorable for Legend Biotech, says RBC Capital
Premium
The Fly
FDA draft guidance favorable for Legend Biotech, says RBC Capital
2M ago
Legend Biotech Signals 2026 Profitability Push and CARVYKTI Expansion in Updated J.P. Morgan Presentation
Premium
Company Announcements
Legend Biotech Signals 2026 Profitability Push and CARVYKTI Expansion in Updated J.P. Morgan Presentation
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100